Search

for
Search:

Glossary

Similar Terms

Learn

0 / 0 results

— no results

Research

5 / 1000+ results

research Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis

15 citations, October 2021 in “Frontiers in Pharmacology”

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

research Microneedles as the Technique of Drug Delivery Enhancement in Diverse Organs and Tissues

140 citations, December 2017 in “Journal of Controlled Release”

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

research Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19

2 citations, October 2020 in “Journal of Pharmacy And Bioallied Sciences”

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

research Bioaesthetics and Regenerative Medicine

1 citations, September 2009 in “Regenerative Medicine”

Bioaesthetic therapies could improve healthcare if they safely regenerate cells, tissues, or organs to restore normal function.

research Wnt Is Back in Drugmakers' Sights, but Is It Druggable?

10 citations, November 2018 in “Nature Biotechnology”

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

View more "big pharma" in research →

Community Join

5 / 1000+ results

community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

in Treatment 118 upvotes 3 months ago

Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

community Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

in Research/Science 88 upvotes 1 year ago

Kintor Pharma completed patient enrollment for a Phase II trial in China for GT20029, a potential new treatment for hair loss. Some believe GT20029 could replace finasteride if effective, while others discuss finasteride's limited efficacy and potential underreported side effects.

community Kintor Pharma Announces Completion of First Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China.

in Research/Science 133 upvotes 1 year ago

Kintor Pharma has started a Phase II trial in China for GT20029, a potential new treatment for hair loss. Participants are discussing the significance, potential release dates, and comparing it to other treatments and technologies like stem cell hair transplants and SAMIRNA.

community Been on the big 3 for 4-5 months.

in Progress Pictures 261 upvotes 1 year ago

A 22-year-old used oral finasteride from Costco and topical Kirkland minoxidil for 4-5 months to treat hair loss, resulting in significant hair regrowth and restored confidence. The "big 3" refers to minoxidil, finasteride, and microneedling as hair loss treatments.

community The theory that explains everything. Please help me make this big!

in Research/Science 2447 upvotes 3 years ago

The post and conversation are about the role of the enzyme 3alpha-hydroxysteroid reductase in hair loss and the potential of compounds like procyanidin B2 and sulforaphane to boost its activity for hair regrowth. Further research is needed to develop effective treatments based on this theory.

View more "big pharma" in community →